MEDICO REMEDIES
|
MEDICO REMEDIES Last 5 Year Balance Sheet History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹17 Cr | ₹17 Cr | ₹17 Cr | ₹4.15 Cr | ₹4.15 Cr |
Equity - Authorised | ₹17 Cr | ₹17 Cr | ₹17 Cr | ₹4.50 Cr | ₹4.50 Cr |
Equity - Issued | ₹17 Cr | ₹17 Cr | ₹17 Cr | ₹4.15 Cr | ₹4.15 Cr |
Equity Paid Up | ₹17 Cr | ₹17 Cr | ₹17 Cr | ₹4.15 Cr | ₹4.15 Cr |
Equity Shares Forfeited | - | - | - | - | - |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | - | - | - | - | - |
Face Value | ₹2.00 | ₹2.00 | ₹10.00 | ₹10.00 | ₹10.00 |
Share Warrants & Outstandings | - | - | - | - | - |
Total Reserves | ₹36 Cr | ₹27 Cr | ₹20 Cr | ₹28 Cr | ₹26 Cr |
Securities Premium | ₹3.33 Cr | ₹3.33 Cr | ₹3.33 Cr | ₹16 Cr | ₹16 Cr |
Capital Reserves | - | - | - | - | - |
Profit & Loss Account Balance | ₹32 Cr | ₹24 Cr | ₹17 Cr | ₹13 Cr | ₹9.91 Cr |
General Reserves | - | - | - | - | - |
Other Reserves | ₹0.24 Cr | ₹0.00 Cr | ₹-0.03 Cr | - | - |
Reserve excluding Revaluation Reserve | ₹36 Cr | ₹27 Cr | ₹20 Cr | ₹28 Cr | ₹26 Cr |
Revaluation reserve | - | - | - | - | - |
Shareholder's Funds | ₹52 Cr | ₹44 Cr | ₹37 Cr | ₹32 Cr | ₹30 Cr |
Minority Interest | - | - | - | - | - |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | - | - | ₹0.66 Cr | ₹4.70 Cr | ₹4.46 Cr |
Non Convertible Debentures | - | - | - | - | - |
Converible Debentures & Bonds | - | - | - | - | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | - | - | ₹1.31 Cr | ₹4.70 Cr | ₹4.46 Cr |
Term Loans - Institutions | - | - | - | - | - |
Other Secured | - | - | ₹-0.65 Cr | - | - |
Unsecured Loans | ₹0.25 Cr | ₹0.25 Cr | ₹0.25 Cr | ₹0.25 Cr | ₹0.25 Cr |
Fixed Deposits - Public | - | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - | - |
Long Term Loan in Foreign Currency | - | - | - | - | - |
Loans - Banks | - | - | - | - | - |
Loans - Govt. | - | - | - | - | - |
Loans - Others | - | - | - | - | - |
Other Unsecured Loan | ₹0.25 Cr | ₹0.25 Cr | ₹0.25 Cr | ₹0.25 Cr | ₹0.25 Cr |
Deferred Tax Assets / Liabilities | ₹0.14 Cr | ₹0.19 Cr | ₹-0.19 Cr | ₹0.16 Cr | ₹0.22 Cr |
Deferred Tax Assets | ₹0.22 Cr | ₹0.07 Cr | ₹0.27 Cr | - | - |
Deferred Tax Liability | ₹0.37 Cr | ₹0.26 Cr | ₹0.08 Cr | ₹0.16 Cr | ₹0.22 Cr |
Other Long Term Liabilities | ₹0.87 Cr | ₹1.59 Cr | ₹1.74 Cr | - | - |
Long Term Trade Payables | - | - | - | - | - |
Long Term Provisions | - | ₹0.06 Cr | ₹0.05 Cr | ₹0.10 Cr | - |
Total Non-Current Liabilities | ₹1.26 Cr | ₹2.08 Cr | ₹2.50 Cr | ₹5.21 Cr | ₹4.92 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹32 Cr | ₹31 Cr | ₹27 Cr | ₹25 Cr | ₹26 Cr |
Sundry Creditors | ₹32 Cr | ₹31 Cr | ₹27 Cr | ₹25 Cr | ₹26 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹3.44 Cr | ₹1.79 Cr | ₹1.57 Cr | ₹4.32 Cr | ₹6.95 Cr |
Bank Overdraft / Short term credit | - | - | - | - | - |
Advances received from customers | ₹1.40 Cr | ₹0.43 Cr | ₹0.14 Cr | ₹1.81 Cr | ₹3.93 Cr |
Interest Accrued But Not Due | - | - | - | - | - |
Share Application Money | - | - | - | - | - |
Current maturity of Debentures & Bonds | - | - | - | - | - |
Current maturity - Others | - | - | - | - | - |
Other Liabilities | ₹2.03 Cr | ₹1.36 Cr | ₹1.44 Cr | ₹2.51 Cr | ₹3.02 Cr |
Short Term Borrowings | ₹6.51 Cr | ₹7.85 Cr | ₹9.06 Cr | ₹8.11 Cr | ₹7.12 Cr |
Secured ST Loans repayable on Demands | ₹5.91 Cr | ₹7.85 Cr | ₹9.06 Cr | ₹8.09 Cr | ₹6.53 Cr |
Working Capital Loans- Sec | ₹5.91 Cr | ₹7.85 Cr | ₹9.06 Cr | ₹8.09 Cr | ₹6.53 Cr |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | - |
Other Unsecured Loans | ₹-5.31 Cr | ₹-7.85 Cr | ₹-9.06 Cr | ₹-8.07 Cr | ₹-5.95 Cr |
Short Term Provisions | ₹3.13 Cr | ₹2.53 Cr | ₹1.84 Cr | ₹0.17 Cr | ₹0.01 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | ₹3.13 Cr | ₹2.50 Cr | ₹1.80 Cr | ₹0.12 Cr | ₹0.01 Cr |
Provision for post retirement benefits | - | - | - | - | - |
Preference Dividend | - | - | - | - | - |
Other Provisions | - | ₹0.04 Cr | ₹0.04 Cr | ₹0.05 Cr | - |
Total Current Liabilities | ₹45 Cr | ₹43 Cr | ₹40 Cr | ₹38 Cr | ₹40 Cr |
Total Liabilities | ₹98 Cr | ₹89 Cr | ₹79 Cr | ₹76 Cr | ₹75 Cr |
ASSETS | |||||
Gross Block | ₹41 Cr | ₹39 Cr | ₹32 Cr | ₹29 Cr | ₹24 Cr |
Less: Accumulated Depreciation | ₹20 Cr | ₹17 Cr | ₹14 Cr | ₹14 Cr | ₹12 Cr |
Less: Impairment of Assets | - | - | - | - | - |
Net Block | ₹21 Cr | ₹22 Cr | ₹18 Cr | ₹15 Cr | ₹13 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | - | - | - | - | ₹2.28 Cr |
Non Current Investments | ₹0.20 Cr | - | - | ₹0.11 Cr | ₹0.15 Cr |
Long Term Investment | ₹0.20 Cr | - | - | ₹0.11 Cr | ₹0.15 Cr |
Quoted | - | - | - | - | - |
Unquoted | ₹0.20 Cr | - | - | ₹0.11 Cr | ₹0.15 Cr |
Long Term Loans & Advances | ₹0.56 Cr | ₹0.85 Cr | ₹1.54 Cr | ₹1.72 Cr | ₹3.59 Cr |
Other Non Current Assets | ₹0.18 Cr | ₹0.16 Cr | ₹0.07 Cr | - | ₹0.06 Cr |
Total Non-Current Assets | ₹22 Cr | ₹23 Cr | ₹20 Cr | ₹17 Cr | ₹19 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | ₹1.36 Cr | ₹1.27 Cr | - | ₹1.06 Cr | - |
Quoted | - | - | - | - | - |
Unquoted | ₹1.36 Cr | ₹1.27 Cr | - | ₹1.06 Cr | - |
Inventories | ₹16 Cr | ₹20 Cr | ₹18 Cr | ₹15 Cr | ₹18 Cr |
Raw Materials | ₹6.67 Cr | ₹7.72 Cr | ₹5.70 Cr | ₹4.13 Cr | ₹6.38 Cr |
Work-in Progress | ₹5.48 Cr | ₹3.69 Cr | ₹3.73 Cr | ₹3.36 Cr | ₹3.05 Cr |
Finished Goods | ₹1.53 Cr | ₹5.36 Cr | ₹4.13 Cr | ₹4.24 Cr | ₹6.10 Cr |
Packing Materials | ₹2.66 Cr | ₹2.93 Cr | ₹4.54 Cr | ₹2.82 Cr | ₹2.73 Cr |
Stores  and Spare | - | - | - | - | - |
Other Inventory | - | - | - | - | - |
Sundry Debtors | ₹50 Cr | ₹36 Cr | ₹30 Cr | ₹27 Cr | ₹24 Cr |
Debtors more than Six months | ₹6.72 Cr | ₹5.92 Cr | ₹5.37 Cr | ₹4.36 Cr | ₹5.16 Cr |
Debtors Others | ₹44 Cr | ₹30 Cr | ₹26 Cr | ₹23 Cr | ₹19 Cr |
Cash and Bank | ₹0.18 Cr | ₹0.91 Cr | ₹2.34 Cr | ₹2.83 Cr | ₹1.42 Cr |
Cash in hand | ₹0.16 Cr | ₹0.14 Cr | ₹0.16 Cr | ₹0.04 Cr | ₹0.15 Cr |
Balances at Bank | ₹0.02 Cr | ₹0.77 Cr | ₹2.18 Cr | ₹2.79 Cr | ₹1.28 Cr |
Other cash and bank balances | - | - | - | - | - |
Other Current Assets | ₹0.43 Cr | ₹0.29 Cr | ₹0.38 Cr | ₹0.52 Cr | ₹0.40 Cr |
Interest accrued on Investments | - | - | - | ₹0.01 Cr | ₹0.04 Cr |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | - | - | - | - | - |
Interest accrued and or due on loans | ₹0.00 Cr | ₹0.02 Cr | ₹0.11 Cr | ₹0.29 Cr | ₹0.16 Cr |
Prepaid Expenses | ₹0.18 Cr | ₹0.11 Cr | ₹0.10 Cr | ₹0.08 Cr | ₹0.14 Cr |
Other current_assets | ₹0.25 Cr | ₹0.17 Cr | ₹0.18 Cr | ₹0.14 Cr | ₹0.06 Cr |
Short Term Loans and Advances | ₹7.84 Cr | ₹7.91 Cr | ₹7.78 Cr | ₹12 Cr | ₹13 Cr |
Advances recoverable in cash or in kind | ₹0.19 Cr | ₹0.13 Cr | ₹0.07 Cr | ₹0.16 Cr | ₹0.15 Cr |
Advance income tax and TDS | ₹2.05 Cr | ₹1.66 Cr | ₹1.46 Cr | - | - |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | - | - | - | - | - |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | ₹5.60 Cr | ₹6.11 Cr | ₹6.25 Cr | ₹12 Cr | ₹13 Cr |
Total Current Assets | ₹76 Cr | ₹66 Cr | ₹59 Cr | ₹58 Cr | ₹57 Cr |
Net Current Assets (Including Current Investments) | ₹31 Cr | ₹23 Cr | ₹19 Cr | ₹21 Cr | ₹16 Cr |
Miscellaneous Expenses not written off | - | - | - | - | - |
Total Assets | ₹98 Cr | ₹89 Cr | ₹79 Cr | ₹76 Cr | ₹75 Cr |
Contingent Liabilities | ₹0.24 Cr | ₹0.23 Cr | - | - | - |
Total Debt | ₹6.75 Cr | ₹8.09 Cr | ₹11 Cr | ₹15 Cr | ₹14 Cr |
Book Value | 6.31 | 5.28 | 22.04 | 78.22 | 71.98 |
Adjusted Book Value | 6.31 | 5.28 | 4.41 | 3.91 | 3.60 |
Compare Balance Sheet of peers of MEDICO REMEDIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MEDICO REMEDIES | ₹467.0 Cr | -3.5% | 15.9% | -29.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹424,346.0 Cr | -2.4% | -6.8% | 50.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹152,494.0 Cr | -3.3% | -6.2% | 64.2% | Stock Analytics | |
CIPLA | ₹121,151.0 Cr | -5.8% | -4% | 21% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹102,300.0 Cr | -4.4% | -8.6% | 14.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹96,402.2 Cr | -1.1% | -6% | 54.5% | Stock Analytics |
MEDICO REMEDIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MEDICO REMEDIES | -3.5% |
15.9% |
-29.3% |
SENSEX | -2.5% |
-5.2% |
19.5% |
You may also like the below Video Courses